-
Notifications
You must be signed in to change notification settings - Fork 0
Introduction
Rapid Prioritization of Tumor Antigens from Immunopeptides!
| Long | Short | Value | Description | Default | Mandatory |
|---|---|---|---|---|---|
| input | i | string (.tsv) | input file path | NA | Y |
| bam | b | string (.bam) | bam file path | NA | Y |
| output | o | string | output file path | NA | Y |
| mode | m | scan, target | mode of match | target | N |
| sequence | s | peptide, nucleotide | sequence type | peptide | N |
| count | c | primary, all | type of countable reads | primary | N |
| equal | e | NA | I is equivalent to L (only available for scan mode) | NA | N |
| thread | @ | integer | the number of threads | 4 | N |
Quick examples
java -Xmx2G -jar bamscan.jar -i test_scan.tsv -b test.bam -o test_scan.scan -m scan -s peptide -e
java -Xmx2G -jar bamscan.jar -i test_target.tsv -b test.bam -o test_target.target -m target -s peptide
A tab-separated value (TSV) format is allowed. This file should include a header.
Scan mode
| Sequence | Any column 1 | Any column 2 | ... | Any column N |
|---|---|---|---|---|
| AAIPPIVTK | Any content 1 | Any content 2 | ... | Any content N |
| FPWQEHEA | Any content 1 | Any content 2 | ... | Any content N |
Target mode
| Sequence | Location | Strand | ... | Any column N |
|---|---|---|---|---|
| AAIPPIVTK | Any content 1 | Any content 2 | ... | Any content N |
| FPWQEHEA | Any content 1 | Any content 2 | ... | Any content N |
Bam file must be sorted by a genomic coordinate and indexed (.bai must exist in the same folder).
- Scan mode: It counts all reads matching the given sequences by traversing all reads and annotates their genomic information
- Target mode: It counts all reads matching the given 3-tuple <Sequence, Location, Strand>. Target mode requires .bai in advance.
The option is not necessary when you know exact sequences. If you identified peptide sequences from MS/MS spectra, we recommend to set this option. This is because there are chances that the sequences are ambiguous about I/L decision in MS/MS sequencing.
Rapid Prioritization of Tumor Antigens from Immunopeptides